One of Deepest Clinical Pipelines on ASX - 3 clinical trials:
2 underway and 1 on track to initiate 1H 2016, all under IND Two Clinical Stage Oncology Drugs 2 drug candidates targeting key cancer pathways » Akt (PTX-200) and Ras (PTX-100)
Distinguished Scientific Provenance Compelling science from leading US institutions – Yale University & Moffitt Cancer Center
Significant investment already made Over $20 M invested to date » Technologies have been awarded multiple prestigious US government grants
Proven Leadership & Management Experienced and proven drug development team on board to aggressively drive product development
Rich Upcoming News Flow Multiple milestone announcements and valuation inflection points across all clinical programs over next 12 to 18 months
Robust IP Patents granted in major jurisdictions extending to 2030
- Forums
- Commodities
- PTX on Bloomberg
PTX on Bloomberg, page-9
-
- There are more pages in this discussion • 14 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)